Novozymes A/S (OTCMKTS:NVZMY) Stock Passes Below Two Hundred Day Moving Average – What’s Next?

Novozymes A/S (OTCMKTS:NVZMY) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $63.12 and traded as low as $56.37. Novozymes A/S shares last traded at $56.58, with a volume of 17,813 shares trading hands.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on NVZMY shares. Citigroup cut Novozymes A/S from a “neutral” rating to a “sell” rating in a research note on Thursday, October 17th. Berenberg Bank raised shares of Novozymes A/S to a “strong-buy” rating in a research report on Tuesday, September 24th. Finally, Barclays upgraded shares of Novozymes A/S to a “strong-buy” rating in a research report on Monday, November 18th.

Novozymes A/S Price Performance

The firm has a market cap of $26.49 billion, a PE ratio of 35.80, a P/E/G ratio of 3.87 and a beta of 0.87. The business has a fifty day moving average price of $58.70 and a two-hundred day moving average price of $63.10.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.